Betsy N. Perry

576 total citations
8 papers, 450 citations indexed

About

Betsy N. Perry is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Betsy N. Perry has authored 8 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Betsy N. Perry's work include Vascular Tumors and Angiosarcomas (3 papers), Vascular Malformations and Hemangiomas (2 papers) and Vascular Malformations Diagnosis and Treatment (2 papers). Betsy N. Perry is often cited by papers focused on Vascular Tumors and Angiosarcomas (3 papers), Vascular Malformations and Hemangiomas (2 papers) and Vascular Malformations Diagnosis and Treatment (2 papers). Betsy N. Perry collaborates with scholars based in United States, Canada and Switzerland. Betsy N. Perry's co-authors include Jack L. Arbiser, Baskaran Govindarajan, Allie M. Sohn, Sulochana S. Bhandarkar, Levi Fried, George D. Yancopoulos, Cynthia Cohen, Ella Ioffe, Marisa Jaconi and Francesca Cerimele and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.

In The Last Decade

Betsy N. Perry

8 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Betsy N. Perry United States	8	199	129	94	65	52	8	450
Minehiko Yokoyama Japan	13	291 1.5×	69 0.5×	48 0.5×	98 1.5×	56 1.1×	23	531
Anh Hua United States	11	117 0.6×	142 1.1×	81 0.9×	41 0.6×	29 0.6×	15	355
Daniel DiSepio United States	11	431 2.2×	140 1.1×	75 0.8×	76 1.2×	79 1.5×	14	744
Connie P. Matthews United States	11	492 2.5×	71 0.6×	150 1.6×	88 1.4×	140 2.7×	12	754
Kazuhiro Nagahira Japan	14	199 1.0×	174 1.3×	66 0.7×	41 0.6×	28 0.5×	26	485
Frederic Bone United States	9	248 1.2×	57 0.4×	56 0.6×	32 0.5×	54 1.0×	11	472
Kyoung Wan Yoon South Korea	14	350 1.8×	190 1.5×	190 2.0×	42 0.6×	71 1.4×	20	690
Jiaoling Chen China	13	132 0.7×	221 1.7×	41 0.4×	35 0.5×	20 0.4×	24	418
Mayank Srivastava United States	7	432 2.2×	106 0.8×	98 1.0×	27 0.4×	227 4.4×	8	999
Shuchi Gupta United States	15	195 1.0×	98 0.8×	28 0.3×	43 0.7×	17 0.3×	32	626

Countries citing papers authored by Betsy N. Perry

Since Specialization

Citations

This map shows the geographic impact of Betsy N. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betsy N. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betsy N. Perry more than expected).

Fields of papers citing papers by Betsy N. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betsy N. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betsy N. Perry. The network helps show where Betsy N. Perry may publish in the future.

Co-authorship network of co-authors of Betsy N. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Betsy N. Perry. A scholar is included among the top collaborators of Betsy N. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betsy N. Perry. Betsy N. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Bhandarkar, Sulochana S., Marisa Jaconi, Levi Fried, et al.. (2009). Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice. Journal of Clinical Investigation. 119(8). 2359–65. 93 indexed citations

Bhandarkar, Sulochana S., Jacqueline Bromberg, Ponniah Selvakumar, et al.. (2008). Tris (Dibenzylideneacetone) Dipalladium, aN-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma GrowthIn vitroandIn vivo. Clinical Cancer Research. 14(18). 5743–5748. 49 indexed citations

Perry, Betsy N., Jacqueline Banyard, Allie M. Sohn, et al.. (2007). AKT1 Overexpression in Endothelial Cells Leads to the Development of Cutaneous Vascular Malformations In Vivo. Archives of Dermatology. 143(4). 504–6. 49 indexed citations

Perry, Betsy N., Cynthia Cohen, Baskaran Govindarajan, George Cotsonis, & Jack L. Arbiser. (2006). Wilms Tumor 1 Expression Present in Most Melanomas but Nearly Absent in Nevi. Archives of Dermatology. 142(8). 1031–4. 13 indexed citations

Perry, Betsy N., Baskaran Govindarajan, Sulochana S. Bhandarkar, et al.. (2006). Pharmacologic Blockade of Angiopoietin-2 Is Efficacious against Model Hemangiomas in Mice. Journal of Investigative Dermatology. 126(10). 2316–2322. 84 indexed citations

Perry, Betsy N. & Jack L. Arbiser. (2006). The Duality of Angiogenesis: Implications for Therapy of Human Disease. Journal of Investigative Dermatology. 126(10). 2160–2166. 15 indexed citations

Arbiser, Jack L., Baskaran Govindarajan, Traci E. Battle, et al.. (2006). Carbazole Is a Naturally Occurring Inhibitor of Angiogenesis and Inflammation Isolated from Antipsoriatic Coal Tar. Journal of Investigative Dermatology. 126(6). 1396–1402. 62 indexed citations

Arbiser, Jack L., Krishna K. Narra, Ramani Ramchandran, et al.. (2006). Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis. Blood. 109(2). 560–565. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact